Natriuretic peptide system and the heart.

Area of Science:

• Cardiology
• Endocrinology
• Molecular Biology

Background:

• The natriuretic peptide (NP) family, including atrial (ANP), brain (BNP), and C-type (CNP) NPs, plays a crucial role in the endocrine system.
• The heart's endocrine function is integral to a complex network involving endocrine, nervous, and immune systems.
• While NPs share biological actions, differences in potency exist, and their regulatory systems require further elucidation.

Purpose of the Study:

• To investigate the detailed production, secretion, and peripheral degradation pathways of BNP and CNP.
• To definitively demonstrate the role of circulating prohormones as precursors to active NP hormones.
• To explore novel therapeutic targets for heart failure by understanding prohormone processing.

Main Methods:

• Review of experimental and clinical studies published in the first decade of the 21st century.
• Analysis of existing data on NP family members (ANP, BNP, CNP).
• Hypothetical modeling of prohormone processing and its potential regulation.

Main Results:

• Existing research supports the heart's endocrine role within a complex biological network.
• The precise pathways for BNP and CNP production, secretion, and degradation remain incompletely understood.
• Evidence suggests circulating prohormones may serve as precursors to active NP hormones, with potential implications for heart failure.

Conclusions:

• Clarifying BNP and CNP metabolic pathways is essential for a comprehensive understanding of NP function.
• The hypothesis of circulating prohormones as active hormone precursors offers a novel perspective on NP regulation.
• Impaired prohormone processing in heart failure patients suggests a potential new pharmacological target for treatment.